CUAM Traditional Chinese Medicine ETF (560080) Rises 2.18%, with Scale Growing by RMB 145 Million Month‑to‑Date

NewTimeSpace (newtimespace.com) News, – As of 10:33 on July 27, 2026, CUAM Traditional Chinese Medicine ETF (560080) rose 2.18%, with its latest price at RMB 0.99.In terms of scale, the ETF’s scale grew by RMB 145 million month‑to‑date, achieving significant growth and ranking 1st among 4 comparable funds in new scale additions.In terms of units, the ETF’s share count grew by 246 million units over the past six months, achieving significant growth and ranking 1st among 4 comparable funds in new share additions.

NewTimeSpace (newtimespace.com) News, – As of 10:33 on July 27, 2026, CUAM Traditional Chinese Medicine ETF (560080) rose 2.18%, with its latest price at RMB 0.99. Over a longer horizon, as of July 24, 2026, the ETF had accumulated a gain of 3.10% over the past 2 weeks, ranking 2nd among 4 comparable funds in terms of gains.

In terms of liquidity, CUAM Traditional Chinese Medicine ETF recorded a turnover rate of 1.30% during the session, with trading volume reaching RMB 33.1626 million. Over a longer period, as of July 24, the ETF’s average daily turnover over the past week was RMB 99.8895 million, ranking first among comparable funds.

In terms of scale, the ETF’s scale grew by RMB 145 million month‑to‑date, achieving significant growth and ranking 1st among 4 comparable funds in new scale additions. (Data source: Wind)

In terms of units, the ETF’s share count grew by 246 million units over the past six months, achieving significant growth and ranking 1st among 4 comparable funds in new share additions. (Data source: Wind)

Data shows that leveraged funds are continuing to position themselves. The latest margin buying amount for CUAM Traditional Chinese Medicine ETF reached RMB 6.4157 million, with its latest margin balance standing at RMB 56.1629 million. (Data source: Wind)

In terms of return capability, as of July 24, 2026, since its inception, the ETF achieved a highest single‑month return of 16.46%, a longest consecutive winning streak of 5 months with a cumulative gain of 20.20%, and an average monthly return of 4.95% during up months. As of July 24, 2026, the ETF’s 3‑month excess annualized return over its benchmark was 6.98%, ranking among the top 2 among 4 comparable funds.

In terms of drawdown, as of July 24, 2026, the ETF’s year‑to‑date drawdown relative to its benchmark was 0.07%, indicating relatively low drawdown risk among comparable funds.

On fees, CUAM Traditional Chinese Medicine ETF charges a management fee of 0.50% and a custody fee of 0.10%, representing the lowest fee structure among comparable funds.

On tracking accuracy, as of July 24, 2026, the ETF’s 3‑year tracking error was 0.043%, the highest tracking precision among comparable funds.

From a valuation perspective, the CSI Traditional Chinese Medicine Index, which the ETF tracks, has a latest price‑to‑earnings (PE‑TTM) ratio of only 21.19x, which is at the 11.51st percentile over the past year, meaning the valuation is lower than for more than 88.49% of the time over the past year, placing it at a historical low.

CUAM Traditional Chinese Medicine ETF closely tracks the CSI Traditional Chinese Medicine Index. The index selects listed company securities whose businesses involve traditional Chinese medicine production and sales as index samples, reflecting the overall performance of listed companies in the traditional Chinese medicine sector.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.